“We are pleased to hear that the Pfizer-BioNTech COVID-19 Vaccine has received full FDA approval. We strongly recommend that everyone receive a COVID-19 vaccine since the vaccines are proven to protect from severe disease. As the Delta variant is now spreading and...
Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals,...
Updated COVID-19 Guidance for Alphas STATEMENT UPDATED: April 16, 2021 Please note, this statement is specific to the United States. If you are an individual with Alpha-1 Antitrypsin Deficiency (Alpha-1) living outside the U.S., please see the specific statements...
Readers discuss equity issues in U.S. eligibility and the decision to send some of the U.S. stockpile to other countries. To the Editor: Re “U.S. Rushes to Expand Covid Vaccine Eligibility in a ‘Race Against Time’” (nytimes.com, March 19): It is encouraging to read...
The Alpha-1 Foundation received the following correspondence from the National Organization for Rare Disorder’s policy team on March 12th, 2021: President Biden signed the American Rescue Plan into law on Thursday, March 11th! This law contains many important...
Summary of major changes: Beginning two weeks after the second dose of a two dose vaccine, it will not be necessary for a fully vaccinated individual to quarantine after exposure to a known COVID-19 individual unless symptoms develop or unless the exposure took place...
